-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Galera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
- Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $551K, a 60.4% decline year-over-year.
- Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.34M, a 45.4% decline year-over-year.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.56M, a 22.4% decline from 2022.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.16M, a 0.93% decline from 2021.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.23M, a 30.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)